MEDIFIRST SOLUTIONS TO PRESENT ITS TIME MACHINE LASER IN MOROCCO AND DUBAI
January 17 2017 - 11:00AM
InvestorsHub NewsWire
Freehold NJ -- January 17, 2017 -- InvestorsHub NewsWire
-- MEDIFIRST SOLUTIONS, INC. (OTCQB:
MFST) (the “Company” or “Medifirst”) would like to update
shareholders regarding its previous announcement about
international sales for its FDA cleared Infrared Time Machine
TTML-8102000 Laser Thermal Therapeutic Device.
Medifirst is pleased to announce that its President and Medical
Director will be presenting its FDA cleared laser technology at a
medical conference on January 27th in Casablanca, Morocco and on
February 1st in Dubai, United Arab Emirates. The conference in
Casablanca will host about 100 physicians who will be specifically
attending to see a presentation and demonstration of the Infrared
Time Machine Laser. In additional to the Company presentation, the
Medical Distributors in both Morocco and Dubai have inquired about
Medifirst’s time frame and capacity to produce and ship large bulk
orders. In anticipation of potential purchase orders, Medifirst has
been ramping up its production capability and inventory. The
Company will also be meeting with representatives of the Moroccan
Ministry of Health who have the authority to purchase medical
devices for all the hospitals in the country. Commented President
Bruce J. Schoengood, “After we complete our demonstration and
presentation, we anticipate finalizing the initial sales and
fulfillment process. This is just the beginning of what we hope is
a long term business relationship in the region.” Additionally, the
Company will be considering setting up a distribution hub in
Morocco that would expedite future orders in that region. In Dubai,
Medifirst will be meeting representatives of a Saudi Arabia based
medical distributor that has requested exclusive rights for four
countries in the region. Continued Schoengood, “We are excited to
have the opportunity to meet distributors who have the buying power
for bulk orders of our Laser. Medifirst will also be meeting with
several Dubai based medical distributors who have requested to meet
the Medifirst management regarding sales and distribution for the
Time Machine Lasers.” Providing pain relief to patients to reduce
reliance on prescription medications is a top priority for these
buyers and all representatives expressed very strong interest in
acquiring The Time Machine Laser for their hospitals, clinics and
patients.
Medifirst would like to announce that it will be using Twitter and
Facebook as its main Social Media Platforms. Follow on Twitter
@Medi_First and for Facebook visit Medifirst Solutions.
About Medifirst Solutions, Inc.
Medifirst Solutions, Inc., in response to its Premarket
Notification 510(k) submission for “The Time Machine” Series Laser,
received clearance from the U.S. Food and Drug Administration
(“FDA”) to market its infrared Time Machine TTML-8102000 Laser
Thermal Therapeutic Device. The Time Machine Series Lasers Model
TTML-8102000 - 810/830nm is intended for use in temporary relief of
minor muscle and joint pain, stiffness, minor arthritis pain,
muscle spasm, temporary increase in local blood circulation and
temporary relaxation of muscles by means of topical elevated tissue
temperature from infrared spectral emissions. Due to the
decrease of inflammation, patients have seen immediate aesthetic
improvements as well, such as in scar and incision healing. The
hand-held laser device, with pin-point accuracy, often gives
patients immediate results with no redness, swelling or down-time.
This unique laser device offers medical professionals an affordable
and effective tool to enhance their treatment protocols for their
patients and provide new revenue streams for their practice. The
laser division will be operated out of Medifirst's wholly owned
subsidiary, Medical Lasers Manufacturer. Visit
www.medifirstsolutions.com for more information.
# # #
Forward-Looking Statements:
The statements in this press release that relate to the company's
expectations with regard to the future impact on the company's
results from new products in development are forward-looking
statements, and may involve risks and uncertainties, some of which
are beyond our control. Such risks and uncertainties are
described in greater detail in our filings with the U.S. Securities
and Exchange Commission. Since the information in this press
release may contain statements that involve risk and uncertainties
and are subject to change at any time, the company's actual results
may differ materially from expected results. We make no
commitment to disclose any subsequent revisions to forward-looking
statements. This release does not constitute an offer to sell or a
solicitation of offers to buy any securities of any entity.
FOR IMMEDIATE RELEASE
Contact: Investor Relations
Phone: (732) 786-8044
Email:
admin@medifirstsolutions.com
Website: www.medifirstsolutions.com